SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2
Nature Medicine2015Vol. 21(12), pp. 1491–1496
Citations Over TimeTop 1% of 2015 papers
Kimberly H. Kim, Woojin Kim, Thomas P. Howard, Francisca Vázquez, Aviad Tsherniak, Jennifer N. Wu, Weishan Wang, Jeffrey R. Haswell, Loren D. Walensky, William C. Hahn, Stuart H. Orkin, Charles W.M. Roberts
Related Papers
- → Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome(2012)519 cited
- → Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma(2020)57 cited
- → SWI/SNF protein expression status in fumarate hydratase–deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients(2018)24 cited
- → GENT-45. HETEROGENEITY OF SWI-SNF COMPONENTS IN MALIGNANT RHABDOID TUMORS(2016)
- → Abstract IA15: SWI/SNF (BAF) chromatin remodeling complexes are frequently mutated in cancer: Mechanisms and vulnerabilities(2018)